When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

After Novo Nordisk and Eli Lilly transformed the market for obesity treatment, a flood of drugmakers has jumped in with ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

MariTide, positioned as a monthly alternative to weekly injections offered by competitors Novo Nordisk NVO ... loss mechanism ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Now a new weight loss drug target may help reduce appetite and burn calories without causing sickness. The discovery could ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

And so we can't lose through that why we're doing what we're doing, which is somebody today is being told you have a terrible ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite ... In 2023, Embark Biotech was acquired by Novo Nordisk to develop next generation ...